| Literature DB >> 18627625 |
Tanja Krüger1, Mandana Ghisari, Philip S Hjelmborg, Bente Deutch, Eva C Bonefeld-Jorgensen.
Abstract
BACKGROUND: The persistent organic pollutants (POPs) are highly lipophilic and resistant to biodegradation and found in e.g. seafood and marine mammals. Greenlandic Inuit have high intake of marine food and thus high POP burden that varies according to local conditions and dietary preference. We do for the very first time report the serum POP related non-steroidal xenohormone activity of Inuit across Greenland. The aims were 1) to determine the integrated xenohormone bioactivities as an exposure biomarker of the actual lipophilic serum POP mixture measuring the effect on estrogen (ER) and androgen receptor (AR) transactivity in citizens from different Greenlandic districts and 2) to evaluate associations to serum POP markers (14 PCBs and 10 pesticides) and lifestyle characteristics.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18627625 PMCID: PMC2503956 DOI: 10.1186/1476-069X-7-38
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Lifestyle characteristics
| Nuuk | Sisimiut | Qaanaaq | All | Nuuk | Sisimiut | Qaanaaq | All | ||
| Age (years) | n | 32 | 51 | 38 | 121 | 45 | 42 | 32 | 119 |
| median | 55 | 30 | 34 | 36 | 38 | 32 | 34 | 35 | |
| mean | 54 | 31 | 33 | 38 | 36 | 33 | 32 | 34 | |
| min | 38 | 18 | 19 | 18 | 19 | 18 | 18 | 18 | |
| max | 72 | 46 | 45 | 72 | 45 | 44 | 44 | 45 | |
| P-value* | <.001 | .15 | .68 | .001 | |||||
| P-value** | <.001 (Nuuk higher) | .07 (no post hoc test) | |||||||
| BMI (kg/m2) | n | 30 | 51 | 38 | 119 | 43 | 42 | 32 | 117 |
| median | 28 | 26 | 27 | 27 | 26 | 26 | 24 | 25 | |
| mean | 27 | 27 | 27 | 27 | 26 | 27 | 25 | 26 | |
| min | 22 | 19 | 20 | 19 | 18 | 19 | 18 | 18 | |
| max | 35 | 36 | 41 | 41 | 32 | 47 | 34 | 47 | |
| P-value* | .03 | .92 | .06 | .04 | |||||
| P-value** | .40 (no post hoc test) | .56 (no post hoc test) | |||||||
| Smoking (years) | n | 29 | 51 | 37 | 117 | 42 | 42 | 30 | 114 |
| median | 35 | 11 | 18 | 18 | 20 | 12 | 16 | 15 | |
| mean | 31 | 12 | 17 | 18 | 16 | 12 | 15 | 14 | |
| min | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| max | 59 | 26 | 30 | 59 | 33 | 27 | 29 | 33 | |
| P-value* | <.001 | .85 | .71 | .001 | |||||
| P-value** | <.001 (all different) | .22 (no post hoc test) | |||||||
| n-3/n-6 | n | 32 | 37 | 38 | 107 | 45 | 38 | 32 | 115 |
| median | 0.55 | 0.22 | 0.39 | 0.35 | 0.25 | 0.29 | 0.37 | 0.29 | |
| mean | 0.69 | 0.29 | 0.50 | 0.48 | 0.29 | 0.32 | 0.43 | 0.34 | |
| min | 0.20 | 0.10 | 0.09 | 0.09 | 0.12 | 0.14 | 0.15 | 0.12 | |
| max | 1.65 | 0.73 | 1.45 | 1.65 | 0.72 | 0.82 | 1.26 | 1.26 | |
| P-value* | <.001 | .18 | .95 | <.001 | |||||
| P-value** | <.001(all different) | <.001 (Qaanaaq higher) | |||||||
| Seabird intake (per month) | n | 30 | 48 | 36 | 114 | 44 | 41 | 31 | 116 |
| median | 2.0 | 1.0 | 1.0 | 2.0 | 1.0 | 1.0 | 1.0 | 1.0 | |
| mean | 4.6 | 2.7 | 2.4 | 3.1 | 1.4 | 1.3 | 3.5 | 1.9 | |
| min | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
| max | 20 | 28 | 20 | 28 | 8 | 2 | 28 | 28 | |
| P-value* | <.001 | .15 | .84 | <.001 | |||||
| P-value** | <.001 (Nuuk higher) | .02 (***) | |||||||
| Dairy food consumption (per month) | n | 31 | 50 | 38 | 119 | 45 | 42 | 32 | 119 |
| median | 36 | 51 | 32 | 40 | 56 | 57 | 37 | 50 | |
| mean | 37 | 49 | 31 | 40 | 53 | 49 | 35 | 47 | |
| min | 4 | 8 | 3 | 3 | 2 | 0 | 0 | 0 | |
| max | 76 | 84 | 58 | 84 | 84 | 84 | 84 | 84 | |
| P-value* | .005 | .64 | .34 | .05 | |||||
| P-value** | <.001 (Sisimiut higher) | .01 (Qaanaaq lower) | |||||||
*: p value for men compared to women within the same district (e.g. Nuuk men and Nuuk women) using Student's t-test.
**: p value for comparison between the districts for the separate genders (e.g. Nuuk vs. Sisimiut vs Qaanaaq and vice versa) using ANOVA, result in the brackets (post hoc LSD/Dunnett T3 test).
***: Qaanaaq borderline higher than Sisimiut (p = 0.07)
Lipid adjusted serum concentrations of the POPs
| Nuuk | Sisimiut | Qaanaaq | All | Nuuk | Sisimiut | Qaanaaq | All | ||
| n | 32 | 51 | 36 | 119 | 44 | 42 | 30 | 116 | |
| ΣPCB (μg/kg lipid) | median | 2,680 | 540 | 1,830 | 1,350 | 300 | 350 | 1,190 | 450 |
| mean | 3,040 | 750 | 2,630 | 1,940 | 490 | 460 | 1,250 | 680 | |
| min | 490 | 130 | 620 | 130 | 97 | 67 | 99 | 67 | |
| max | 11,100 | 2,370 | 7,100 | 11,100 | 2,430 | 1,380 | 3,490 | 3,490 | |
| P-value* | <.001 | .001 | <.001 | <.001 | |||||
| P-value** | <.001 (Sisimiut lower) | <.001 (Qaanaaq higher) | |||||||
| n | 32 | 51 | 36 | 119 | 44 | 42 | 30 | 116 | |
| Σpesticide (μg/kg lipid) | median | 3,500 | 740 | 2,590 | 1,590 | 480 | 500 | 1,670 | 640 |
| mean | 4,070 | 1,010 | 3,740 | 2,660 | 680 | 700 | 1,890 | 1,000 | |
| min | 410 | 140 | 620 | 140 | 84 | 76 | 78 | 76 | |
| max | 19,100 | 3,540 | 14,400 | 19,100 | 2,880 | 3,010 | 7,530 | 7,530 | |
| P-value* | <.001 | .01 | .002 | <.001 | |||||
| P-value** | <.001 (Sisimiut lower) | <.001 (Qaanaaq higher) | |||||||
| n | 32 | 51 | 36 | 119 | 44 | 42 | 30 | 116 | |
| ΣPOP (μg/kg lipid) | median | 6,420 | 1,360 | 4,390 | 3,020 | 760 | 830 | 2,850 | 1,110 |
| mean | 7,250 | 1,770 | 6,380 | 4,640 | 1,190 | 1,170 | 3,140 | 1,690 | |
| min | 910 | 290 | 1,240 | 290 | 180 | 150 | 190 | 150 | |
| max | 30,800 | 5,910 | 19,900 | 30,800 | 5,370 | 4,350 | 10,800 | 10,800 | |
| P-value* | <.001 | .003 | <.001 | <.001 | |||||
| P-value** | <.001 (Sisimiut lower) | <.001 (Qaanaaq higher) | |||||||
ΣPCB: sum of 14 PCB congeners. Σpesticide: sum of the 10 pesticide residues. ΣPOP: sum of all 24 POPs.
*: p value for men compared to women within the same district (e.g. Nuuk men and Nuuk women) using Student's t-test.
**: p value for comparison between the districts for the separate genders (e.g. Nuuk vs Sisimiut vs Qaanaaq and vice versa) using ANOVA, result in the brackets (post hoc LSD/Dunnett T3 test).
Xenoestrogenic and xenoandrogenic transactivities of the serum POP fraction
| Nuuk | Sisimiut | Qaanaaq | All | Nuuk | Sisimiut | Qaanaaq | All | ||
| 32 | 51 | 36 | 119 | 45 | 42 | 32 | 118 | ||
| median | 1.00 | 0.95 | 0.97 | 0.97 | 1.05 | 0.90 | 1.01 | 0.99 | |
| mean ± SD | 1.00 ± | 0.94 ± | 0.98 ± | 0.97 ± | 1.03 ± | 0.94 ± | 1.00 ± | 0.99 ± | |
| % agonistic | 6 | 2 | 14 | 7 | 4 | 5 | 6 | 5 | |
| % decreased | 9 | 33 | 25 | 24 | 9 | 20 | 28 | 18 | |
| P-value* | .09 | .59 | .24 | .07 | |||||
| P-value** | .02 (Nuuk and Sisimiut different) | .001 (Sisimiut different) | |||||||
| 32 | 51 | 38 | 121 | 45 | 42 | 32 | 118 | ||
| median | 0.97 | 0.82 | 0.93 | 0.89 | 1.03 | 0.96 | 0.91 | 0.96 | |
| mean ± SD | 0.99 ± | 0.84 ± | 0.91 ± | 0.90 ± | 1.02 ± | 0.95 ± | 0.90 ± | 0.96 ± | |
| % further increased | 6 | 2 | 0 | 3 | 34 | 10 | 6 | 14 | |
| % antagonistic | 16 | 75 | 37 | 47 | 34 | 0 | 50 | 23 | |
| P-value* | .19 | <.001 | .76 | <.001 | |||||
| P-value** | <.001 (all different) | <.001 (Nuuk different) | |||||||
| 34 | 33 | 38 | 110 | 41 | 28 | 33 | 102 | ||
| median | 1.21 | 1.12 | 1.13 | 1.16 | 1.14 | 0.99 | 1.01 | 1.06 | |
| mean ± SD | 1.22 ± | 1.20 ± | 1.16 ± | 1.20 ± | 1.17 ± | 1.01 ± | 1.09 ± | 1.10 ± | |
| % agonistic | 18 | 22 | 11 | 17 | 15 | 0 | 12 | 10 | |
| % decreased | 6 | 3 | 0 | 3 | 2 | 0 | 0 | 1 | |
| P-value* | .50 | .01 | .22 | .01 | |||||
| P-value** | .47 (no post hoc test) | .07 (no post hoc test) | |||||||
| 34 | 33 | 38 | 110 | 41 | 28 | 33 | 102 | ||
| median | 1.38 | 1.17 | 0.84 | 1.17 | 0.94 | 0.80 | 0.84 | 0.87 | |
| mean ± SD | 1.40 ± | 1.24 ± | 0.90 ± | 1.18 ± | 0.99 ± | 0.81 ± | 0.86 ± | 0.90 ± | |
| % further increased | 50 | 17 | 5 | 23 | 5 | 0 | 6 | 4 | |
| % antagonistic | 0 | 6 | 24 | 11 | 12 | 25 | 21 | 19 | |
| P-value* | <.001 | <.001 | .49 | <.001 | |||||
| P-value** | <.001 (all different) | .001 (Nuuk different) | |||||||
| 28 | 33 | 33 | 99 | 41 | 28 | 29 | 98 | ||
| mean ± SD | 1.19 ± | 1.29 ± | 1.19 ± | 1.23 ± | 1.14 ± | 1.09 ± | 1.08 ± | 1.11 ± | |
| P-value* | .51 | .02 | .09 | .004 | |||||
| P-value** | .46 (no post hoc test) | .64 (no post hoc test) | |||||||
| 28 | 33 | 34 | 100 | 41 | 28 | 29 | 98 | ||
| mean ± SD | 1.41 ± | 1.50 ± | 1.03 ± | 1.33 ± | 0.98 ± | 0.89 ± | 0.96 ± | 0.95 ± | |
| P-value* | <.001 | <.001 | .36 | <.001 | |||||
| P-value** | <.001 (Qaanaaq different) | .30 (no post hoc test) | |||||||
XER and XAR: ER and AR transactivity of serum extract alone, respectively; XERcomp and XARcomp: competitive receptor transactivity upon co-treatment with EC50 of E2 or R1881, respectively.
% agonistic and % decreased indicates a significant increase or decrease, respectively, for the XER and XAR activity compared to the activity of the solvent control which was set to 1. % further increased and % antagonist indicates a further significant increase or decrease, respectively, for the XERcomp and XARcomp transactivity compared to the transactivity of the E2-EC50or R1881-EC50 solvent control, which was set to 1.
RLU/μg protein: The determined luciferase activity was corrected for cell density using protein measurements and expressed in relative luciferase units per microgram protein (RLU/μg protein).
*: p value for men compared to women within the same district (e.g. Nuuk men and Nuuk women) using Student's t-test.
**: p value for comparison between the districts for the separate genders (e.g. Nuuk vs Sisimiut vs Qaanaaq and vice versa) using ANOVA, result in the brackets (post hoc LSD/Dunnett T3 test).
Figure 1Xenohormone serum transactivities in the Greenlandic districts. Scatterplots of the ln-transformed xenoestrogenic and xenoandrogenic serum transactivities versus ΣPOP for men and women in Nuuk, Sisimiut and Qaanaaq.
Pearson 2-tailed correlation between xenohormone transactivities and lifestyle characteristics
| Nuuk | Sisimiut | Qaanaaq | All | ||||||||||
| n | β | p | n | β | p | n | β | p | n | β | p | ||
| age | 32 | .19 | .30 | 36 | .18 | .28 | 119 | .14 | .14 | ||||
| n-3/n-6 | 32 | .29 | .11 | 37 | -.25 | .14 | 36 | .08 | .65 | ||||
| BMI | 30 | .04 | .85 | 51 | -.19 | .18 | 36 | -.09 | .61 | 117 | -.07 | .47 | |
| smokeyrs | 29 | .28 | .15 | 51 | -.26 | .07 | |||||||
| seabird | 29 | -.25 | .20 | 47 | .17 | .26 | 33 | -.15 | .41 | 109 | .06 | .54 | |
| dairy food | 31 | .06 | .74 | 50 | -.08 | .59 | 36 | .03 | .88 | 117 | -.07 | .44 | |
| age | 32 | -.11 | .56 | 51 | -.05 | .71 | 38 | .12 | .46 | ||||
| n-3/n-6 | 37 | -.24 | .15 | 38 | -.18 | .29 | 107 | .09 | .37 | ||||
| BMI | 30 | -.29 | .12 | 51 | -.08 | .58 | 38 | -.17 | .31 | 119 | -.09 | .31 | |
| smokeyrs | 29 | .08 | .70 | 51 | .20 | .16 | 37 | .24 | .16 | ||||
| seabird | 29 | -.25 | .19 | 47 | -.04 | .79 | 35 | -.01 | .94 | 111 | .12 | .21 | |
| dairy food | 31 | -.09 | .64 | 50 | .02 | .90 | 38 | -.002 | .99 | 119 | -.14 | .13 | |
| Nuuk | Sisimiut | Qaanaaq | All | ||||||||||
| n | β | p | n | β | p | n | β | p | n | β | p | ||
| age | 42 | -.11 | .51 | 32 | .23 | .21 | 119 | -.01 | .93 | ||||
| n-3/n-6 | 45 | .09 | .55 | 38 | -.17 | .32 | 32 | .01 | .96 | 115 | -.05 | .57 | |
| BMI | 43 | -.17 | .27 | 42 | .11 | .50 | 32 | -.21 | .24 | 117 | -.04 | .70 | |
| smokeyrs | 42 | .05 | .77 | 30 | .28 | .14 | 114 | .04 | .69 | ||||
| seabird | 38 | -.04 | .81 | 39 | .04 | .81 | 31 | .04 | .83 | 108 | .05 | .63 | |
| dairy food | 45 | .03 | .84 | 41 | -.05 | .77 | 31 | -.24 | .19 | 117 | -.06 | .51 | |
| age | 45 | .98 | .58 | 42 | -.07 | .68 | 32 | -.06 | .74 | 119 | .07 | .46 | |
| n-3/n-6 | 45 | -.11 | .47 | 38 | -.09 | .59 | 32 | -.32 | .08 | ||||
| BMI | 43 | .04 | .80 | 42 | -.05 | .77 | 32 | -.18 | .32 | 117 | -.05 | .61 | |
| smokeyrs | 42 | .11 | .49 | 42 | .10 | .53 | 30 | -.06 | .74 | 114 | .08 | .40 | |
| seabird | 39 | .01 | .96 | 31 | -.08 | .68 | 108 | -.04 | .67 | ||||
| dairy food | 45 | -.10 | .52 | 41 | .02 | .93 | 31 | -.08 | .65 | 117 | .05 | .59 | |
| Nuuk | Sisimiut | Qaanaaq | All | ||||||||||
| n | β | p | n | β | p | n | β | p | n | β | p | ||
| age | 34 | -.11 | .53 | 33 | .05 | .79 | 38 | -.03 | .87 | 105 | .02 | .82 | |
| n-3/n-6 | 34 | .01 | .96 | 27 | -.12 | .57 | 38 | .04 | .81 | 99 | .001 | .99 | |
| BMI | 32 | -.03 | .89 | 33 | -.21 | .25 | 38 | -.09 | .59 | 103 | -.10 | .30 | |
| smokeyrs | 31 | -.24 | .19 | 33 | .12 | .49 | 36 | .09 | .59 | 100 | -.01 | .96 | |
| seabird | 31 | .19 | .32 | 36 | .13 | .45 | 99 | .02 | .84 | ||||
| dairy food | 33 | .20 | .25 | 32 | -.21 | .26 | 38 | .14 | .39 | 103 | .09 | .37 | |
| age | 34 | -.21 | .24 | 33 | .12 | .53 | 38 | .09 | .61 | ||||
| n-3/n-6 | 34 | .03 | .87 | 27 | -.15 | .44 | 38 | .003 | .99 | 99 | .03 | .78 | |
| BMI | 32 | .07 | .70 | 33 | -.17 | .33 | 38 | .11 | .51 | 103 | .01 | .92 | |
| smokeyrs | 31 | -.32 | .08 | 33 | -.04 | .81 | 36 | .09 | .59 | 100 | .16 | .12 | |
| seabird | 31 | .002 | .99 | 32 | -.12 | .53 | 36 | .08 | .66 | 99 | .13 | .19 | |
| dairy food | 33 | .20 | .27 | 32 | -.17 | .36 | 38 | .21 | .22 | 103 | .17 | .09 | |
| Nuuk | Sisimiut | Qaanaaq | All | ||||||||||
| n | β | p | n | β | p | n | β | p | n | β | p | ||
| age | 41 | -.11 | .49 | 28 | .04 | .83 | 33 | -.10 | .59 | 102 | -.02 | .83 | |
| n-3/n-6 | 26 | .08 | .69 | 33 | -.19 | .28 | 100 | .03 | .80 | ||||
| BMI | 39 | -.19 | .26 | 28 | -.23 | .24 | 33 | -.04 | .81 | 100 | -.16 | .12 | |
| smokeyrs | 38 | -.25 | .13 | 28 | .22 | .26 | 31 | -.03 | .86 | 97 | -.03 | .76 | |
| seabird | 36 | -.13 | .45 | 27 | -.30 | .13 | 32 | -.13 | .48 | 95 | -.14 | .19 | |
| dairy food | 41 | .08 | .60 | 31 | -.30 | .10 | 99 | .05 | .63 | ||||
| age | 41 | -.07 | .69 | 28 | -.09 | .65 | 33 | -.03 | .85 | 102 | .03 | .80 | |
| n-3/n-6 | 41 | .19 | .22 | 26 | .04 | .84 | 33 | .08 | .66 | 100 | .002 | .98 | |
| BMI | 39 | .26 | .11 | 28 | .20 | .31 | 33 | -.04 | .84 | 100 | .10 | .31 | |
| smokeyrs | 38 | .01 | .97 | 28 | -.09 | .65 | 31 | .08 | .69 | 97 | .05 | .63 | |
| seabird | 36 | -.11 | .52 | 27 | -.07 | .72 | 32 | -.15 | .43 | 95 | -.14 | .18 | |
| dairy food | 41 | -.04 | .81 | 27 | -.04 | .86 | 31 | .21 | .27 | 99 | .14 | .18 | |
Linear regression analyses of xenohormone transactivities before and upon adjustment for lifestyle characteristics
| n | β | p | n | β | p | n | β | p | n | β | p | ||
| Σ | Non-adjusted | 32 | -.26 | .15 | 51 | -.08 | .56 | 36 | -.24 | .17 | |||
| +age | - | - | - | - | - | - | - | - | - | 119 | -.00 | .99 | |
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 105 | .27 | .06 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | 105 | .10 | .47 | |
| Σ | Non-adjusted | 32 | -.32 | .07 | 51 | -.13 | .37 | 36 | -.21 | .21 | 119 | .17 | .07 |
| +age | - | - | - | - | - | - | - | - | - | 119 | -.07 | .50 | |
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 105 | .13 | .39 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | 105 | -.03 | .86 | |
| Σ | Non-adjusted | 32 | -.30 | .09 | 51 | -.11 | .45 | 36 | -.24 | .17 | |||
| +age | - | - | - | - | - | - | - | - | - | 119 | -.04 | .71 | |
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 105 | .21 | .16 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | 105 | .04 | .80 | |
| n | β | p | n | β | p | n | β | p | n | β | p | ||
| Σ | Non-adjusted | 44 | .11 | .49 | 42 | -.06 | .70 | 30 | -.01 | .96 | 116 | -.14 | .14 |
| +age | - | - | - | - | - | - | - | - | - | 116 | -.18 | .07 | |
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 112 | .05 | .62 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | 112 | .01 | .92 | |
| Σ | Non-adjusted | 44 | .02 | .90 | 42 | -.09 | .58 | 30 | -.14 | .48 | |||
| +age | - | - | - | - | - | - | - | - | - | ||||
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 112 | -.02 | .84 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | 112 | -.06 | .58 | |
| Σ | Non-adjusted | 44 | .05 | .74 | 42 | -.08 | .62 | 30 | -.10 | .61 | 116 | -.18 | .06 |
| +age | - | - | - | - | - | - | - | - | - | ||||
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 112 | .01 | .94 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | 112 | -.04 | .76 | |
| n | β | p | n | β | p | n | β | p | n | β | p | ||
| Σ | Non-adjusted | 34 | -.07 | .70 | 33 | .003 | .99 | 37 | .17 | .32 | 104 | -.05 | .62* |
| +age | - | - | - | - | - | - | - | - | - | ||||
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 98 | -.22 | .14 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | ||||
| Σ | Non-adjusted | 34 | -.01 | .96 | 33 | .06 | .76 | 37 | .10 | .54 | 104 | -.04 | 68* |
| +age | - | - | - | - | - | - | - | - | - | ||||
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 98 | -.20 | .19 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | ||||
| Σ | Non-adjusted | 34 | -.04 | .83 | 33 | .04 | .85 | 37 | .13 | .44 | 104 | -.04 | .67* |
| +age | - | - | - | - | - | - | - | - | - | ||||
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 98 | -.21 | .17 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | ||||
| n | β | p | n | β | p | n | β | p | n | β | p | ||
| Σ | Non-adjusted | 40 | .09 | .60 | 28 | -.21 | .29 | 31 | .13 | .47 | 99 | -.06 | .56 |
| +age | - | - | - | - | - | - | - | - | - | 99 | -.07 | .50 | |
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 97 | -.04 | .75 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | 97 | -.06 | .68 | |
| Σ | Non-adjusted | 40 | .15 | .35 | 28 | -.26 | .19 | 31 | .08 | .67 | 99 | -.06 | 55 |
| +age | - | - | - | - | - | - | - | - | - | 99 | -.07 | .50 | |
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 97 | -.05 | .74 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | 97 | -.06 | .67 | |
| Σ | Non-adjusted | 40 | .13 | .43 | 28 | -.23 | .24 | 31 | .10 | .59 | 99 | -.06 | 57 |
| +age | - | - | - | - | - | - | - | - | - | 99 | -.07 | .52 | |
| +n-3/n-6 | - | - | - | - | - | - | - | - | - | 97 | -.04 | .77 | |
| +age+n-3/n-6 | - | - | - | - | - | - | - | - | - | 97 | -.06 | .70 | |
Adjustment for BMI, smoker years and bird intake did not further change the data.
The overall association between the POP markers and xenohormone transactivity across the study groups were evaluated using multiple linear regressions analysis. Homogeneity across the districts was observed (see Additional file 1) and to improve the statistical power and the overall trend of the study groups the combined male and female data across the districts was evaluated.
*: The combined data of Sisimiut and Qaanaaq men was significantly negatively correlated to non-adjusted as well as age adjusted POPs.
-: The data of the single districts were not adjusted for lifestyle characteristics because of the few cases in each district (n = 31 – 40).